gC1qR Expression in Normal and Pathologic Human Tissues
Open Access
- 25 May 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Histochemistry & Cytochemistry
- Vol. 60 (6) , 467-474
Abstract
The gC1qR (i.e., gC1q receptor, gC1q binding protein, p32, p33) is a multifunctional cellular protein that interacts with components of the complement, kinin, and coagulation cascades and select microbial pathogens. Enhanced gC1qR expression has been reported in adenocarcinomas arising in a variety of organs. The present study compared gC1qR expression in normal, inflammatory, dysplastic, and malignant tissue of epithelial and mesenchymal origin. gC1qR expression was visualized in tissue sections by immunohistochemistry using the 60.11 monoclonal antibody (i.e., IgG1 mouse monoclonal antibody directed against gC1qR) and the UltraVision LP Detection System. Sections were counterstained with hematoxylin and examined by light microscopy. Strongest gC1qR expression was noted in epithelial tumors of breast, prostate, liver, lung, and colon, as well as in squamous and basal cell carcinoma of the skin. However, increased gC1qR staining was appreciated also in inflammatory and proliferative lesions of the same cell types, as well as in normal continuously dividing cells. In contrast, tumors of mesenchymal origin generally stained weakly, with the exception of osteoblasts, which stained in both benign and malignant tissues. The data suggest that increased gC1qR expression may be a marker of benign and pathologic cell proliferation, particularly in cells of epithelial origin, with potential diagnostic and therapeutic applications.Keywords
This publication has 38 references indexed in Scilit:
- C1q induces in vivo angiogenesis and promotes wound healingMolecular Immunology, 2011
- Cell-surface Receptor for Complement Component C1q (gC1qR) Is a Key Regulator for Lamellipodia Formation and Cancer MetastasisJournal of Biological Chemistry, 2011
- The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting StrategiesJournal of Biological Chemistry, 2011
- Integrated Proteomics and Genomics Analysis Reveals a Novel Mesenchymal to Epithelial Reverting Transition in Leiomyosarcoma through Regulation of SlugMolecular & Cellular Proteomics, 2010
- Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative PhosphorylationMolecular and Cellular Biology, 2010
- Mitochondrial/Cell-Surface Protein p32/gC1qR as a Molecular Target in Tumor Cells and Tumor StromaCancer Research, 2008
- Regulated complement deposition on the surface of human endothelial cells: Effect of tobacco smoke and shear stressThrombosis Research, 2008
- Oval cells in hepatitis B virus‐positive and hepatitis C virus‐positive liver cirrhosis: histological and ultrastructural studyHistopathology, 2006
- Hyaluronan Binding Protein 1 (HABP1)/C1QBP/p32 Is an Endogenous Substrate for MAP Kinase and Is Translocated to the Nucleus upon Mitogenic StimulationBiochemical and Biophysical Research Communications, 2002
- Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cellsBlood, 2001